These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21148126)

  • 1. Gene from a psoriasis susceptibility locus primes the skin for inflammation.
    Wolf R; Mascia F; Dharamsi A; Howard OM; Cataisson C; Bliskovski V; Winston J; Feigenbaum L; Lichti U; Ruzicka T; Chavakis T; Yuspa SH
    Sci Transl Med; 2010 Dec; 2(61):61ra90. PubMed ID: 21148126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis.
    Hegyi Z; Zwicker S; Bureik D; Peric M; Koglin S; Batycka-Baran A; Prinz JC; Ruzicka T; Schauber J; Wolf R
    J Invest Dermatol; 2012 May; 132(5):1416-24. PubMed ID: 22402441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis.
    Batycka-Baran A; Hattinger E; Zwicker S; Summer B; Zack Howard OM; Thomas P; Szepietowski JC; Ruzicka T; Prinz JC; Wolf R
    J Dermatol Sci; 2015 Sep; 79(3):214-21. PubMed ID: 26055798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
    Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
    Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.
    Wolf R; Howard OM; Dong HF; Voscopoulos C; Boeshans K; Winston J; Divi R; Gunsior M; Goldsmith P; Ahvazi B; Chavakis T; Oppenheim JJ; Yuspa SH
    J Immunol; 2008 Jul; 181(2):1499-506. PubMed ID: 18606705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
    Johnston A; Fritz Y; Dawes SM; Diaconu D; Al-Attar PM; Guzman AM; Chen CS; Fu W; Gudjonsson JE; McCormick TS; Ward NL
    J Immunol; 2013 Mar; 190(5):2252-62. PubMed ID: 23359500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis.
    Batycka-Baran A; Maj J; Wolf R; Szepietowski JC
    J Immunol Res; 2014; 2014():628289. PubMed ID: 24901012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.
    Sa SM; Valdez PA; Wu J; Jung K; Zhong F; Hall L; Kasman I; Winer J; Modrusan Z; Danilenko DM; Ouyang W
    J Immunol; 2007 Feb; 178(4):2229-40. PubMed ID: 17277128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function.
    Wolf R; Ruzicka T; Yuspa SH
    Amino Acids; 2011 Oct; 41(4):789-96. PubMed ID: 20596736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation.
    Zwicker S; Hattinger E; Bureik D; Batycka-Baran A; Schmidt A; Gerber PA; Rothenfusser S; Gilliet M; Ruzicka T; Wolf R
    PLoS One; 2017; 12(4):e0175153. PubMed ID: 28422993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
    Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
    J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
    Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
    J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human S100A7 Induces Mature Interleukin1α Expression by RAGE-p38 MAPK-Calpain1 Pathway in Psoriasis.
    Lei H; Li X; Jing B; Xu H; Wu Y
    PLoS One; 2017; 12(1):e0169788. PubMed ID: 28060905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis: genetic associations and immune system changes.
    Liu Y; Krueger JG; Bowcock AM
    Genes Immun; 2007 Jan; 8(1):1-12. PubMed ID: 17093502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium.
    Wolf R; Lewerenz V; Büchau AS; Walz M; Ruzicka T
    Exp Dermatol; 2007 Aug; 16(8):685-91. PubMed ID: 17620096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE signaling sustains inflammation and promotes tumor development.
    Gebhardt C; Riehl A; Durchdewald M; Németh J; Fürstenberger G; Müller-Decker K; Enk A; Arnold B; Bierhaus A; Nawroth PP; Hess J; Angel P
    J Exp Med; 2008 Feb; 205(2):275-85. PubMed ID: 18208974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases.
    Kurpet K; Chwatko G
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAC1 activation drives pathologic interactions between the epidermis and immune cells.
    Winge MC; Ohyama B; Dey CN; Boxer LM; Li W; Ehsani-Chimeh N; Truong AK; Wu D; Armstrong AW; Makino T; Davidson M; Starcevic D; Kislat A; Nguyen NT; Hashimoto T; Homey B; Khavari PA; Bradley M; Waterman EA; Marinkovich MP
    J Clin Invest; 2016 Jul; 126(7):2661-77. PubMed ID: 27294528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A7: A rAMPing up AMP molecule in psoriasis.
    D'Amico F; Skarmoutsou E; Granata M; Trovato C; Rossi GA; Mazzarino MC
    Cytokine Growth Factor Rev; 2016 Dec; 32():97-104. PubMed ID: 26872860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms.
    Ji YZ; Liu SR
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31710084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.